管理層發言
Good morning. And welcome to Olin Corporation's Second Quarter 2026 Earnings Conference Call. To withdraw your question, please note this event is being recorded. I would now like to turn the conference over to Steve A. Keenan, Olin's Director of Investor Relations. Please go ahead, Steve.
Thank you, operator. Good morning, everyone. We appreciate you joining us today to review Olin's second quarter 2026 results. Please keep in mind that today's discussion, together with the associated slides, as well as the question and answer session that follows, will include statements regarding estimates or expectations of future performance. Please note these are forward-looking statements, and that Olin's actual results could differ materially from those projected. Some of the factors that could cause actual results to differ from our projections are described, without limitation, in the risk factors section of our most recent Form 10-K and in yesterday's second quarter earnings press release. A copy of today's transcript and slides will be available on our website in the Investors section under Past Events. Our earnings press release and related financial data and information are available under Press Releases. With me this morning are Kenneth Todd Lane, Olin's President and CEO, and Todd A. Slater, Olin's CFO. We will start with some prepared remarks, then we will look forward to taking your questions. Let me now turn the call over to Olin's President and CEO, Kenneth Todd Lane.
Thank you, Steve, and thanks to everyone for joining us today. We appreciate your interest in Olin and taking the time to join us on such a busy morning. Let's begin with some highlights from the second quarter on slide 3. On June 16, we were very pleased to announce our planned merger with Huntsman. Bringing together two highly complementary businesses will create a world-scale, vertically integrated North American-focused chemical leader with more than $12 billion in sales. The second quarter also saw the conflict in the Middle East disrupt chemical supply chains and increase prices. Markets rebalanced as the quarter progressed, although significant uncertainty remains. Caustic soda and EDC export pricing was a second quarter bright spot reflecting the supply chain disruptions at the beginning of the quarter. This was partially offset by an unplanned VCM shutdown at our Freeport, Texas facility. Epoxy also achieved higher pricing across all products during the second quarter as hydrocarbon feedstock costs rose and availability tightened. Epoxy demand remained weak in Europe, but the U.S. saw moderate seasonal demand improvement in the quarter. Winchester's commercial ammunition recovery continues as year-over-year demand improves and our pricing initiatives to offset rising metals costs start to gain traction. Domestic and international military sales continue to show strength. Against the backdrop of weak demand and volatile global events, Olin's self-help efforts remain top of mind. Our value-first commercial approach continues to preserve ECU values while our Beyond250 initiative is delivering structural cost reductions. Now let's turn to slide 4 for an update on our recently announced merger with Huntsman, which creates a $12 billion vertically integrated, cost-advantaged North American chemicals leader. Since announcing the transaction, we made significant progress in a short period of time. We filed our definitive proxy on July 13, and Olin shareholders have already begun casting their votes as we approach the August 25 special shareholder meeting. Todd and I have spent recent weeks on the road with the Huntsman management team meeting with both Olin and Huntsman shareholders, listening to feedback, and discussing our value creation thesis. The response has been very supportive and reinforces our excitement about the deal. In the third quarter, we will begin pre-closing integration planning led by Todd. This is a very important first step toward realizing the $400 million of synergies quickly following the close, which we continue to expect in the first half of 2027. Now let's turn to slide 5 for a closer look at our chlor-alkali products and vinyls second quarter performance. Early in the quarter, the conflict in the Middle East drove supply chain interruptions and dramatically higher feedstock and energy costs, resulting in higher prices for many products. As supply chains rebalanced during the quarter, export pricing for both EDC and caustic soda trended lower but remained above pre-conflict levels. These export price trends will offset stronger domestic caustic pricing in the third quarter. We expect product availability to tighten in the fourth quarter driven by persistently higher feedstock and energy costs as well as several planned industry shutdowns. As discussed on our Q1 earnings call, we had an unplanned outage in early May at our Freeport, Texas VCM plant. While the outage was disappointing, it was an isolated equipment issue that we have addressed. We were able to restart the plant by mid-May but VCM will be running at reduced operating rates through the third quarter while we complete final repairs. This outage resulted in a $40 million penalty to second quarter adjusted EBITDA and will have an estimated $20 million impact on the third quarter. Second quarter merchant chlorine sales improved seasonally, supported by stronger water treatment, refrigerant, and other derivative demand. During the third quarter, several planned chlorine customer shutdowns will reduce volumes, but chlorine pricing remains stable. Finally, we continue to make very good progress on our Beyond250 structural cost savings initiatives, and we are on track to deliver on our commitments. Turning to slide 6, let's review our epoxy results. During the second quarter, our epoxy business posted its best results in more than three years. As the conflict in the Middle East unfolded, our epoxy team implemented price increases to offset rising raw material and transportation costs. Security of supply became paramount to customers, supporting Olin's strategy to grow our epoxy participation in both the U.S. and Europe. During the second quarter, U.S. epoxy resin demand experienced moderate seasonal improvement while European demand remained flat. Our epoxy cost initiatives continue to pay off. Between our new Stade, Germany supply agreements and our Guarulhos, Brazil plant closure, we have reduced epoxy structural costs by more than $50 million per year. These actions, in combination with our commercial strategy for increased participation, have returned this business to positive earnings. Now let's take a look at Winchester on slide 7. Monthly out-the-door commercial ammunition sales have improved year-over-year as consumer demand strengthens. Winchester continues to increase prices to offset rising raw material costs, particularly copper and brass. Both of these factors have resulted in year-over-year improvement to adjusted EBITDA. Winchester is continuing its disciplined approach to working capital and inventory management as we see our commercial backlog growth. The third quarter is typically our strongest for commercial ammunition demand due to the fall hunting season, and we expect that to drive sequential earnings improvement. Domestic and international military ammunition and project sales continue to be strong. I will now turn the call over to Todd for a look at our financial highlights.
Thanks, Kenneth. I will now walk through our cash flow, liquidity position, and overall financial foundation. Our top priority remains generating strong cash flow, preserving liquidity, and maintaining flexibility through the cycle. We ended the quarter with $1.2 billion of available liquidity, including the undrawn capacity under our revolving credit facility. Our debt profile remains well structured with no bond maturities before 2029. During the first half of 2026, working capital increased by $183 million reflecting our normal seasonal build, which we expect to liquidate in the second half of the year. The increase also included $93 million of payments against previously accrued reserves related to the resolution of the legacy Shintech litigation matters. We expect to pay the remaining $100 million during the second half of 2026. As a result of these litigation-related cash payments, we expect to end the year with a year-over-year increase in outstanding debt and a leverage ratio of approximately 4.5 times. As we further strengthen our financial resilience, any excess cash flow will be used to reduce our outstanding debt. Our capital allocation priorities also remain consistent and disciplined. First, we continue to target 2026 capital spending of approximately $200 million with investments focused on the safe, reliable, and efficient operation of our assets. Second, we expect to continue our long history of uninterrupted quarterly dividend payments. Third, excluding approximately $195 million of cash payments to resolve legacy litigation matters I just discussed, we expect working capital to be essentially flat for the full year 2026. And finally, we continue to expect 2026 to be a cash-free tax year, plus or minus approximately $20 million. Within Beyond250, we are expanding our focus on people and process improvements and remain on track to deliver more than $100 million of incremental structural cost savings in 2026. In addition, based on the progress we are seeing across the organization, we are increasingly confident we will exceed our $250 million target by 2028. In summary, our teams remain focused on cash generation, cost discipline, and execution of Beyond250. Our strong financial foundation enables Olin to continue executing our value-first commercial approach while maintaining disciplined capital allocation, a prudent capital structure, and resilient cash flows. With that, Kenneth, I will turn the call back to you.
Thank you, Todd. I will finish up with slide 9 and our outlook for the third quarter. We expect stronger domestic caustic soda pricing. Export volumes for both caustic soda and EDC should improve but will largely be offset by lower export pricing. In epoxy, stable volumes and an improved mix are expected to benefit third quarter results. However, this will be more than offset by higher European FIFO costs. Winchester third quarter results are expected to improve driven by higher commercial volumes and pricing, partially offset by higher metals costs. We will continue to remain focused on working capital. Against the backdrop of continued global uncertainty, we expect Chemicals adjusted EBITDA to be relatively flat in the third quarter. We do expect a modest earnings improvement at Winchester, although corporate costs are expected to be a sequential headwind. Overall, adjusted EBITDA should again be in the range of $100 million to $200 million. Stepping back, we remain confident in the long-term outlook for our business. Chlor-alkali continues to benefit from an attractive supply-demand outlook relative to other commodity chemical value chains, supported by recent industry capacity closures and limited new capacity additions globally. As the industry leader in chlor-alkali, we are very well positioned to benefit from these favorable dynamics. Our epoxy business has returned to profitability and continues to improve. At Winchester, self-help actions taken in late 2025, disciplined cost and working capital management, and a recovering commercial ammunition market continue to support improved performance. Across Olin, we are making good progress on our priorities: delivering record safety performance in 2026, streamlining work processes, creating new reliability road maps, and adding resources to support execution. We are leveraging digital tools and AI across our plants to quickly identify inefficiencies, reduce costs, and improve asset reliability. Finally, we are reinforcing accountability by aligning our short-term incentive program with site-level safety, reliability, and cost performance targets, further strengthening our performance-driven culture. Operator, we are now ready to begin the Q&A.
分析師問答
Thank you. We will now begin the question-and-answer session. To ask a question, you may press *, then 1 on your touch-tone phone. If you are using a speakerphone, please pick up your handset before pressing the keys. At this time, we will pause momentarily to assemble the roster. First question will come from Frank Mitsch with Fermium Research. Please go ahead.
Hi, guys. Good morning. This is Eva on for Frank. My first question was around the conflict in the Middle East and where would you say this has been the biggest impact within Olin? If the war were to drag on for a few more months, what are the implications for the company?
Good morning, Eva. Good to hear your voice. The biggest impact we felt was in the second quarter, when we saw prices and concern around supply disruptions really ramp up early in the quarter. As we said in the prepared comments, we saw that abate as we went through the quarter. Going forward, as markets have rebalanced, we expect globally that costs have risen, particularly for producers outside the U.S., which will likely put a higher floor under prices. We recognize some softness in export pricing for EDC and caustic today; a lot of that is digesting the volume that was produced when everyone saw that peak in pricing. Even producers that were cash negative before prices ran up saw an opportunity to produce and move product. That will be digested through the third quarter and then, as I said, I think things will start to tighten up more in the fourth quarter. There is a lot of capacity that is going to be down. Demand continues to be stable; we are not seeing any erosion in demand. So we saw the run-up in Q2. We expect things to normalize in Q3 at a higher cost level, which should benefit us in the fourth quarter.
The next question will come from Hassan Ahmed with Alembic Global. Please go ahead.
Good morning, Kenneth and Todd. I wanted to revisit the same topic a little differently to get a clearer view on near-term supply-demand dynamics for chlorovinyls. First, what are your views about the return of capacity across the Middle East as and when the conflict ends? Above and beyond that, we've seen an escalation in natural gas prices in Europe — would you share your views around rationalization there? And on the demand side, across a variety of chemical chains, particularly in Asia, we saw a fair amount of inventory destocking. Could we expect a restocking cycle over the next couple of quarters?
Good morning, Hassan. That's a lot of questions, so I'll try to address each. In terms of short-term supply-demand implications, we saw a run-up in Q2 across chlor-alkali and PVC operating rates. Some Asian ethylene-based producers cut back, carbide ramped up, and Europe saw a spike in operating rates in Q2, but many of those have reversed. There was a lump of production in Q2; now people have cut back on operating rates, and that will start to filter through the market in Q3 and Q4. I'm less worried about the return of capacity in the Middle East; it's hard to predict. The primary focus is what happens in China. We have seen operating rates in China already reduced in Q3, and that will take time to filter into supply-demand balances, but it will. Combined with some outages we see, particularly in North America, that should be constructive as we finish out the year. In Europe, we did see a run-up in operating rates, but that has come back as prices normalized and concerns about supply eased. Regarding destocking, that's important to watch. Customers initially bought ahead of disruptions, but now they will consume inventory hoping costs will come down. That could change if they need to restock, but underlying housing and automotive demand remains stable rather than recovering. These dynamics are volatile and hard to predict, which is why we provided a wide range for the third quarter outlook.
The next question will come from Gabe Hajde with Wells Fargo. Please go ahead.
Good morning, Kenneth, Steve, Todd. Thanks for taking the question. I wanted to ask about the 4.5x leverage target at the end of the year. You provided some building blocks, Todd. If I model a normal working capital release and the $100 million payment, I'm getting debt maybe around $2.75 billion by year-end, which would imply full-year EBITDA of about $610 million. I'm trying to juxtapose that with comments about improved dynamics in Q4 for the chlor-alkali business. Can you walk through how we should think about the leverage target and the potential upside if Q4 dynamics improve?
Good morning, Gabe. I will start, then I'll let Todd add to it. As we've been saying over the course of the second quarter and as we talked about our merger with Huntsman, deleveraging is a priority for Olin. We'll be very focused on that. The teams here are extremely focused on cash generation and reducing working capital. There is a lot of volatility in the geopolitical environment, and that won't change anytime soon. We saw a run-up in Q2 that was beneficial for us, and you'll see a bit of giveback in Q3 as export prices reflect some pullback. There will still be outages occurring, and as we saw last year, industry rationalization of capacity with relatively good demand, albeit not growing, was already improving dynamics. I think we'll get back to a more stable environment that reflects late Q1 and late Q2, but the Q2 spike will be an anomaly as things find a more balanced way forward in a very uncertain world. Todd, I'll let you talk to the balance sheet.
No problem. Gabe, thanks for the question. We do not provide an annual EBITDA outlook, but we do expect net debt to increase year-over-year from year-end 2025 to year-end 2026, driven by roughly $195 million of legacy litigation payments that we are obligated to make in 2026. We would expect to end the year in that roughly 4.5 times range on leverage. I want to remind everyone on the call about cash flow. Our trailing 12-month adjusted EBITDA at the end of June is roughly $570 million. Olin generated roughly $100 million of levered free cash flow in the last trailing four quarters even at those levels of adjusted EBITDA. That cash flow has been utilized to repay legacy litigation matters. When I talk about levered free cash flow, that is after paying the dividend, funding our capital spending, paying all interest, and meeting our capital allocation priorities. Olin generates cash flow at very low levels of earnings, which I think is a distinction among many of our commodity chemical peers.
The next question will come from Josh Spector with UBS. Please go ahead.
Good morning. This is Chris Peretti on for Josh. Kenneth, for the chlor-alkali business, with the VCM fixed in place, do you expect to get that $20 million back in the fourth quarter? And for epoxy, how large is the FIFO headwind in the third quarter? Is pricing elevated enough to offset increasing raw materials, or do you need another round of price increases to keep things where they are?
Hi, Chris. Good morning. As we get the VCM asset back to full capacity at the end of the quarter, we do expect to see recovery of that in the fourth quarter, all going well at this point. Todd, you want to take the second part of that question?
Sure. Epoxy announced price increases here in the third quarter commensurate with increased hydrocarbon and raw material costs that they have seen most recently from the escalation of the conflict in the Middle East. We would expect it to be a headwind on FIFO between Q2 and Q3, but we clearly expect epoxy to continue to generate positive EBITDA for the third quarter.
The next question will come from Matthew DeYoe with Bank of America. Please go ahead.
Good morning, guys. This is Hakim Saffo on for Matthew. You mentioned that U.S. epoxy resin demand experienced seasonal improvement. Was the main driver something you expect to continue into Q3? And in Europe, what needs to happen for demand to improve — just more construction and industrial demand?
Hakim, good morning. We saw moderate seasonal improvement in the U.S., which was expected due to normal seasonality — things like coatings tied to construction activity. In Europe, we have not seen that seasonal improvement; the market was flat in Q2. For Europe to improve, you would need better housing and industrial demand. However, Europe faces higher energy costs that are impacting producers and overall economic activity, and I don't see anything in the short term that will quickly change that. Our cost reductions in Europe will remain extremely important; we are not counting on the market to help us in Europe anytime soon.
The next question will come from Arun Viswanathan with RBC Capital Markets. Please go ahead.
Hi. This is Adam on for Arun. Have you broken out how much the FIFO benefit was that you called out for epoxy? Given the reversal of that benefit next quarter, do you expect overall segment earnings to improve, or should they be more in line with where they were this quarter?
Thanks. We do not provide a specific quantification for FIFO benefit. As we think about Chemicals earnings, we would expect Chemicals earnings to be sequentially similar between Q3 and Q2. We would expect epoxy to be slightly lower in the third quarter compared to Q2, with chlor-alkali better. The epoxy decline will be driven by a lower benefit from FIFO and the effect of higher raw material costs running through the epoxy P&L. We have not quantified a specific number associated with that, but that is how you should think about sequential Q3 versus Q2.
The next question will come from Matthew Blair with TPH. Please go ahead.
Thanks and good morning. Slide 15 shows that chlorine prices fell in Q2 even though most of the chlorine derivatives moved up in price, like PVC and EDC. You also mentioned that your merchant chlorine sales were pretty strong in Q2. Could you help us understand this dynamic and what caused chlorine to come down — was it mostly a supply-driven response? And finally, can you confirm you expect chlorine prices to be relatively stable in Q3?
Good morning, Matthew. Yes, that's correct. Chlorine pricing movements tend to be small on an illiquid market, so the chlorine price by itself is not highly material. It's more important to look at the ECU with the derivatives across the portfolio. The published chlorine prices have limited transparency, so I wouldn't put too much emphasis solely on the chlorine print. Going forward, we expect chlorine pricing to be stable.
The next question will come from John Roberts with Mizuho. Please go ahead.
Hi. Good morning. This is Saurabh Deshpande on for John. I want to start with Winchester: you said there is less import competition on the commercial side. Is that related to the conflicts outside the U.S., metal costs, or something else that is reducing the competition?
Thanks for your question.
Good morning. The lower imports are related to tariffs. If you look at the tariffs placed on imported ammunition, they have fluctuated but are now around 20% in some cases or slightly higher. That continues to be a tailwind for the commercial Winchester business. We have faced headwinds related to higher costs for copper and brass, which we've addressed with price increases, but the tariffs provide helpful support.
The next question will come from Peter Osterland with Truist Securities. Please go ahead.
Hi. This is Alec on for Peter. Going forward, what have you achieved so far regarding the $30 million of cost outs in Winchester, and what remaining buckets are you targeting? If military and commercial are improving, does the cost outlook change?
Good morning, Alec. We are doing well on the Winchester cost-outs. We have already recognized a significant portion of the $30 million through efficiency improvements. In Q4 of last year, we took actions to right-size shifts and improve operations at our sites, and we've made a lot of progress. We also kicked off our Beyond250 efforts in Q3, bringing in outside expertise to further improve efficiencies, particularly at the Lake City facility in Missouri. We are confident in the $30 million target and believe Winchester is likely to exceed that number once we complete the Lake City assessment.
The next question will come from Roger Spitz with Bank of America. Please go ahead.
Thanks very much. The Shintech $100 million payment — is that on slide 14 or is that in addition? I just wasn't clear on that.
Good morning, Roger. Todd, you want to take that?
Roger, the $100 million payment referenced for the back half of 2026 is not on slide 14. Slide 14 contains our full-year modeling assumptions. However, in our outlook expectations for net debt to increase for the full year, that does include the $100 million payment in the back half of 2026.
As there are no further questions, this concludes our question-and-answer session. I would like to turn the conference back over to Kenneth Todd Lane for closing comments.
Thank you, Nick. I just want to thank everyone for joining us and thank you for your interest in Olin. I wish you all a very safe and relaxing weekend.
Thank you for attending today's presentation. You may now disconnect.